跳至主要内容
临床试验/NCT01263652
NCT01263652撤回不适用

The Relationship Between Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients

Western Galilee Hospital-Nahariya0 个研究点开始时间: 2010年12月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
主要终点
pain scores on visual analog scale

研究概览

简要总结

The investigators will conduct a randomized double blind study, to determine whether patient analgesic delivery mode preference affects pain reduction quality in non-surgical spine patients.

The patients will receive both intra-muscular and oral non-narcotic analgesics and placebo. During the study period, pain reduction parameters will be collected. At the end of the study period, the investigators will attempt to find a correlation between pre-study patient preferences and the quality of the pain reduction achieved.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
15 Years 至 100 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with chronic and acute back pain

排除标准

  • Recent Spine Surgery

研究组 & 干预措施

IMmed

Active Comparator

Patients receiving intra-muscular medication and oral placebo

干预措施: Diclofenac hydroxyethylpyrrolidine (Drug)

IMmed

Active Comparator

Patients receiving intra-muscular medication and oral placebo

干预措施: orphenadrine (Drug)

IMmed

Active Comparator

Patients receiving intra-muscular medication and oral placebo

干预措施: Tramadol (Drug)

IMmed

Active Comparator

Patients receiving intra-muscular medication and oral placebo

干预措施: Dipyrone (Drug)

POmed

Active Comparator

Patients receiving intra-muscular placebo and oral medication

干预措施: Diclofenac hydroxyethylpyrrolidine (Drug)

POmed

Active Comparator

Patients receiving intra-muscular placebo and oral medication

干预措施: orphenadrine (Drug)

POmed

Active Comparator

Patients receiving intra-muscular placebo and oral medication

干预措施: Tramadol (Drug)

POmed

Active Comparator

Patients receiving intra-muscular placebo and oral medication

干预措施: Dipyrone (Drug)

结局指标

主要结局

pain scores on visual analog scale

时间窗: visual analog scale will be mesuered before and one hour following every pain medication delivery

up to 7 days for each patient per hospitalization

次要结局

  • patient preference Questionnaire(before first analgesic administration at the current hositalization)
  • Patient Questionnaire assessing pain and pain relief(Before administaration of pain control medication and one hour following analgesic administration)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Nimrod Rahamimov

Investigator

Western Galilee Hospital-Nahariya

相似试验